Skip to content
★ Sign in to follow
豪展

豪展 Stock: price and insider trades · Taiwan

TW·Mcap NT$1.4BHealth Care

豪展: what insiders have been doing

Insider filings for 豪展 are scarce in the TWSE / TPEx (MOPS) feed, the latest one published on 27 November 2015. This page will fill in as new trades are disclosed. These figures are compiled from regulatory filings published by TWSE / TPEx (MOPS). They describe what insiders did and are not a recommendation.

Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 8,314 of 26,911 companies
61.1
score / 100
Value
48
Quality
74
FCF yld-14%
Earn yld6.6%
EV/EBITDA9.4x
ROE23%
Gross mgn32%
Net mgn10.0%
Debt/EBITDA0.2x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

NT$37
Analyst consensus
·
Income statement
RevenueNT$936.4M
Gross profitNT$295.7M32% margin
EBITDANT$154.5M17% margin
Net incomeNT$93.2M23.8% margin
Valuation
PER (trailing)6.1x
P/Book1.3x
Beta0.33
Balance sheet & cash
Market capNT$1.4B
Total debtNT$31.9M
Free Cash Flow-NT$197.7M
Debt / Equity23%
Profitability & ownership
ROE22.6%
ROA2.2%
% insiders42.6%
% institutions0.0%
Last declaration on 27 November 2015
Declarations1 total
  • ●
    SupervisorExecutives
    €71kest.0MOPS
    75,000 sharesShareTPExTWMOPS:4735:104/11/27:巫典勳之配偶:0915g72

1 of 1 declaration

About 豪展

豪展 is a company listed on the XTAI market, specializing in various financial services.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations